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Notable among gaps in the achievement of the global health Millennium Development Goals (MDG) are shortcomings
in addressing maternal health, an issue addressed in the fifth MDG. This shortfall is particularly acute in Sub-Saharan
Africa (SSA), where over half of all maternal deaths occur each year. While there is not as yet a comprehensive
understanding of the biological and social causes of maternal death in SSA, it is evident that poverty, gendered economic
marginalization, social disruptions, hindered access to care, unevenness in the quality of care, illegal and clandestine
abortions, and infections are all critical factors. Beyond these factors, this paper presents a review of the existing literature
on maternal health in SSA to argue that syndemics constitute a significant additional source of maternal morbidity and
mortality in the region. Increasing focus on the nature, prevention, and treatment of syndemics, as a result, should be part
and parcel of improving maternal health in SSA.
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Review
Quandaries in health development and pregnancy
in Sub-Saharan Africa
As 2015 draws near, Gorman [1] highlights the fact that
although there has been notable progress in several critical
areas of global health, one of the Millennium Develop-
ment Goals (MDGs) adopted at the 2000 Millennium
Summit “has been particularly recalcitrant to progress…
namely, improving maternal health.” The risk of a woman
dying as a result of pregnancy or childbirth is about one in
six in the poorest nations of the world compared with
about one in 30,000 in the wealthy nations of Northern
Europe [2]. The United Nations Secretariat [3] estimated
that almost 300,000 maternal deaths occurred in 2010,
56% of them in Sub-Saharan Africa (SSA). With a mater-
nal mortality rate of 640 maternal deaths per 100,000 live
births [4], achieving MDG-5 in SSA is proving to be a for-
midable challenge. More broadly, maternal survival hasCorrespondence: Merrill.Singer@Uconn.edu
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reproduction in any medium, provided the orbeen a comparatively neglected area in global health [5,6],
suggestive of the longstanding primacy of focusing on
fetuses and children, and not mothers, in maternal and
child health programming [7]. Reflective of this shortcom-
ing, as Gorman affirms, there is not as yet a full under-
standing of the biological and social causes of maternal
death in SSA, although it is clear that poverty, gendered
economic marginalization, social disruptions, access to care,
quality of care, illegal and clandestine abortions, and infec-
tions are all critical factors [8-10]. The question has been
raised: is achieving MDG-5 an impossible dream [11]?
Pregnancy is a unique immune condition that often
has been characterized as a highly risky state for the
mother and fetus alike. As Mor and Cardenas [12] note,
for example, “Pregnant women in malaria-endemic re-
gions are more susceptible to malaria infection during
the first half of the pregnancy and this risk gradually
declines during the second half. Lassa fever, caused by
infection with an arenavirus showed a higher rate of case
fatality in pregnant women particularly in the third
trimester”. Additionally, pregnancy may increase suscep-
tibility and increase rates of mortality due to various
infection diseases [13].
Compared to other world regions, infection as a cause
of maternal death is especially prominent in SSA [14].
While it is evident that vulnerability to infection duringhis is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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the stage of the pregnancy, the nature of the disease
challenge, the health of the mother prior to becoming
pregnant, and access to quality health care, most existing
discussions consider the immune challenge mounted by
a single infectious agent. But what of the ability of the
immune systems of pregnant women to respond to
comorbid disease challenges, including diseases that are
known to interact adversely in dually or multiply in-
fected individuals? Moreover, what of the role of recipro-
cal actions during pregnancy involving the deleterious
interface of infectious and noninfectious conditions?
Adverse disease interactions, or syndemics, have been
shown in recent years to play a significant detrimental
role in the health of vulnerable populations [15].
The purpose of this paper is to emphasize the poten-
tial degree of influence of syndemics based on a review
of an uneven, in many ways limited, but nonetheless
suggestive, literature on the health of pregnant women
in SSA. Focusing specifically on women’s health, I argue
that among the issues that must be addressed to a
greater extent in health development efforts in the
region are the emergence of an increased and more
systematic awareness of, and response to, the syndemics
of pregnancy.
The biosocial model of syndemics
The predominant biomedical and epidemiological models
of disease stress isolated focus on individual threats to
health. Such models rest on three underlying assumptions:
every case of illness has a single underlying cause, a spe-
cific and identifiable disease is the source of each illness,
and removal or reduction of the disease will produce a
return to health [16]. Yet, as Valderas et al. [17] stress, on
a daily basis biomedical practitioners treat “individuals
with multiple coexisting diseases, who are now the norm
rather the exception”. That the great majority of patients,
as well as sufferers not in care, have more than one health
problem at any given moment needs to be explicitly
acknowledged if the health impacts of disease complexity
are to be effectively addressed.
Feinstein [18] introduced the concept of comorbidity
to label the co-occurrence of diseases or other disorders.
It has become increasingly apparent how important this
concept is in health. A study of comorbidity in Canada,
for example, concluded that findings on the high preva-
lence of multiple conditions “call into question the very
organization of our health services [19].” In SSA, it is
likely that the significance of comorbidity for population
health and individual patient treatment is several magni-
tudes greater than in Canada, creating what Levitt et al.
[20] term a health “collision course”: “Noncommunicable
diseases … are emerging, and their risk factors are be-
coming more common as lifestyles change and rates ofurbanization increase. Simultaneously, epidemics of in-
fectious diseases persist, and HIV/AIDS has taken hold
in the region”. Indeed, it has been suggested that SSA is
in the midst of a profound health transition involving a
quadruple burden of infectious, noninfectious, injury-
related, and perinatal and maternal health problems
[21]. As a result, Starfield [22], who believes focus
should not be on individual threads but on the “tapestry
of morbidity,” suggests that patients “should be charac-
terized by their morbidity burden and, more import-
antly, by the patterns of morbidity that they experience
with time”.
With an understanding of the force of comorbidity in
health, a syndemics orientation draws attention to two
critical issues. First, diseases can transition beyond co-
presence to consequential adverse interaction. Second,
the clustering of diseases in populations and the en-
hanced vulnerability of particular groups is often a result
of social conditions and the unequal structure of social re-
lationships. The differences between the terms comorbid
and syndemic, as Mustanski et al. stress [23], is not simply
semantic. Research guided by a comorbidity model tends
to focus on the disease boundaries, overlaps, and prio-
ritization, while syndemic research directs attention to
“communities experiencing co-occurring epidemics that
additively increase negative health consequences [23]”.
The adverse synergistic interaction of diseases in syn-
demics, in other words, multiplies the burden of disease in
a population, and, under given conditions, can escalate
contagion, disease progression, disability, and mortality.
Stall et al. [24] introduced the syndemic production
model, which posits that the greater the number of condi-
tions in a syndemic interaction, the more adverse the
health outcomes.
Vulnerability to syndemics involves both factors that
put groups in harm’s way for clusters of disease, as well
as factors that contribute to the weakening of bodies,
the degrading of immune capacities, the failing of social
support systems, and the disruption or inaccessibility of
healthcare services. Commonly, these are social condi-
tions, such as structural inequalities, which produce
chronic stress, inadequate diets, exposure to physical
and emotional traumas, gender or other discrimination,
and involvement in risky behaviors such as survival or
coping mechanisms [15,25]. These kinds of social en-
cumbrances “get under the skin” and have direct impact
not only on disease development and progression, but
on deleterious disease interaction as well.
Syndemics, in short, involve both biological and social
factors and their pathways of interaction, mechanisms
of disease promotion, and enhanced health impacts.
Syndemic theory draws attention to, and provides a frame-
work for, the analysis of these biosocial interactions, in-
cluding their causes and consequences for human life and
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entwined biological and social vulnerabilities and health
profiles of various populations [24,29-35]. The biosocial
contingencies of pregnancy generally and how these are
enhanced in particular settings in SSA constitute a press-
ing domain of syndemics investigation.
The syndemics of pregnancy in SSA can be categorized
for the purposes of analysis into three types: infectious
syndemics, mixed infectious/noninfectious syndemics, and
noninfectious syndemics. Each of these will be reviewed in
turn based on the available literature.
Infectious syndemics of pregnancy in Africa
Infectious diseases still cause the majority (69%) of deaths
in SSA [36]. Several diseases are of particular note, includ-
ing HIV, malaria, and tuberculosis (TB).
Syndemics of HIV disease
Meta-analysis of available global research on the contribu-
tion of HIV disease to maternal mortality has identified a
pooled attributable risk across studies of 994 per 100,000
women [37]. Of the world’s regions, the contribution of
HIV disease to maternal mortality is highest in SSA,
accounting for an estimated 207,000 (9%) of deaths
between 1990 and 2008 among pregnant and immedi-
ate postpartum women [4]. Other estimates suggest
pregnancy-related HIV deaths as high as 25% of all mater-
nal deaths for the region [37]. A secondary analysis of
pooled community-based data for Sub-Saharan countries
by Zaba et al. [38] found that excess mortality attributable
to HIV was 51.8 (ranging across data sets from 47.8–53.8)
per 1,000 person-years in women who were not pregnant
or postpartum, and 11.8 (8.4–15.3) per 1,000 person-years
in pregnant or postpartum women. These researchers
also found that HIV-infected pregnant or postpartum
women have a mortality rate that is eight times higher
than their HIV-uninfected counterparts. Sub-Saharan
countries experiencing increases in maternal deaths in
the midst of the campaign to achieve MDG-5, such as
Botswana, Swaziland, Lesotho, and South Africa, are
all in the subregion of the continent with the highest
prevalence of HIV disease. This recognized significant
impact of HIV disease on maternal health notwithstand-
ing, there is recognition that “remarkably little is known
about the mortality attributable to HIV during the preg-
nancy and postpartum period [37]”. One area in need of
greater understanding is the role of HIV-related disease
interactions in maternal illnesses (e.g., anemia, postpar-
tum hemorrhage and puerperal sepsis) and death.
What is known is that HIV disease is highly syndemo-
genic [15]. A key reason it has become one of the major
diseases of human history is its considerable capacity to
participate in damaging disease interactions of three types.
First, interactions with opportunistic diseases that generallyare only able to take hold because of immunodeficiency
resulting from HIV disease. Second, interactions with a
set of commonly non-opportunistic diseases, such as TB,
hepatitis, malaria, and various STDs. Finally, HIV disease
interacts adversely with various noninfectious diseases and
disorders, including food insufficiency/malnourishment,
among others. Each of these will be discussed in turn.
HIV interaction with opportunistic diseases
There are multiple opportunistic diseases found among
HIV-infected pregnant women [39,40]. A study of this
population at a large HIV treatment center in Lagos,
Nigeria found that the most prevalent opportunistic dis-
eases were oropharyngeal and vaginal candidiasis (24.0%
of identified opportunistic disease cases), bacterial infec-
tions including pneumonia (12.9%), Herpes zoster (5.3%),
and diarrheal diseases (18.1%) [41]. These opportunistic
diseases were found to be an important predictor of
anemia, a well-recognized risk for heightened morbidity
and mortality in pregnant women [42,43]. Analysis of data
from the Saving Mothers Report, 2005–2007 by Moran
and Moodley [44] found that the most common cause of
maternal deaths in known HIV-infected women in South
Africa (accounting for 43.7% of all maternal deaths) were
nonpregnancy-specific opportunistic diseases such as me-
ningitis and pneumonia. Opportunistic diseases, including
meningitis, toxoplasmosis, encephalitis, and pneumonia,
were found by Onakewhor and coworkers [45] to be
important factors in maternal mortality in Benin City,
Nigeria.
An examination was conducted by Djigma et al. [46] on
the prevalence of bacterial vaginosis—the most common
vaginal infection in women of childbearing age—in 251
HIV-positive compared to 200 HIV-negative women at a
maternal and child health program in Burkina Faso. They
found a range of vaginal pathogens, including several asso-
ciated with sterility. Nugent’s scores, a Gram-stain scoring
system used to diagnose bacterial vaginosis, were sig-
nificantly higher in HIV-positive women (p < 0.001). As
these studies suggest, various opportunistic diseases re-
main important factors shaping maternal health among
HIV-infected women in SSA.
HIV interaction with non-opportunistic diseases
One of the significant non-opportunistic diseases with
which HIV disease increasingly interacts in SSA is TB
[47]. While sometimes described as an opportunistic
disease, TB has a protracted history as a serious human
ailment that long predates the emergence of HIV disease
[48]. According to the World Health Organization, ma-
ternal TB, which may be harder to detect because of the
masking effects of pregnancy, causes a two-fold increase
in vaginal bleeding, eclampsia, and pre-eclampsia [49].
Recent research has identified the development of active
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factor for maternal health [50-52]. Because of several path-
ways of interaction, including HIV reactivation of latent
TB and bidirectional disease enhancement involving accel-
erated progression of both HIV disease and TB, in com-
bination, these two diseases have been shown to have
significantly greater impact than the mere addition of their
individual effects. This pattern was described by Pillay
et al. [53] based on a review of existing studies showing
that approximately one-sixth of all maternal deaths in re-
ferral health centers in southern Africa were associated
with TB/HIV coinfection. Further, over one-third (37%) of
HIV-infected mothers who were dually infected with TB
were severely immunocompromised, with CD4 counts of
fewer than 200 cells/microL compared with 14-19% in
mothers enrolled in mother-to-child intervention trials in
Europe.
Exemplary of TB/HIV coinfection research, Khan et al.
[54] examined maternal mortality at King Edward III
Hospital in Durban, South Africa, located in an area
where TB and HIV have emerged as significant entwined
contributors to maternal mortality. They found a mortal-
ity rate of 323/100,000 among HIV-infected women,
compared to 148.6/100,000 among uninfected women.
Ninety-three percent (14 of 15) of mothers diagnosed
with TB were coinfected with HIV. The hospital-based
mortality rate for TB and HIV coinfection was 121.7/
1,000; for TB without HIV coinfection, this rate was
38.5/1,000 or about one third the rate of HIV-infected
women. Generally, in late HIV disease, women are more
likely to have clinical TB, so active TB may be a marker of
late HIV disease, as well as an increased risk of death as a
result of the comorbidity. Still unresolved in the literature
is the issue of pregnancy effects (e.g., added biological and
metabolic costs) of TB/HIV interaction, progression, and
adverse outcomes.
Another HIV syndemic threat to maternal health in-
volves coinfection with malaria. At early stages in preg-
nancy, a transient depression of cell-mediated immunity
occurs that increases susceptibility to malaria, especially
in primagravid and secundigravid women [55]. Inde-
pendent of HIV, maternal malaria is associated with
anemia and maternal mortality [56-58]. It is estimated
that 15% of maternal anemia in SSA is linked to malaria
and a range of other adverse outcomes [59,60]. It is fur-
ther estimated that one million pregnancies per year in
the region are adversely complicated by coinfection of
malaria and HIV disease [61].
Maternal HIV disease is associated with an increased
risk of maternal malaria in women of all gravidities in
endemic areas, but perhaps not equally so [62]. In a study
of women who presented at two rural hospitals in south-
ern Malawi for antenatal care and for delivery, prevalence
of HIV disease was 25.6% [63]. In this sample, amongwomen who were pregnant for the first time, prevalence
for malaria at enrollment was 56.3% in HIV-infected, and
36.5% in HIV-uninfected, women. For multigravid women,
the corresponding rates were 23.8% and 11.0%, res-
pectively. HIV-infected primagravid women exhibited in-
creased malaria prevalence at all gestational stages. The
relative risk for malaria infection in HIV-infected women
compared to HIV-uninfected women was significantly in-
creased in most parity groups, including women with
more than three prior pregnancies (95% CI: 0.31–5.29),
suggesting that parity-specific immunity to malaria (found
in HIV-negative women) was impaired in dually infected
women. Malaria prevalence at delivery remained high in
HIV-infected women even among those pharmaceutically
treated for infection.
The importance of HIV in malaria infection is further
indicated by a study in Kinshasa, Democratic Republic
of Congo. In the study, Modia et al. [64] compared 146
HIV-infected and 149 HIV-uninfected mothers. Placental
biopsies confirmed the presence or absence of placental
malaria. These researchers found that the placental malar-
ial infection prevalence was 91% among HIV-infected
mothers but only 53.7% in HIV-uninfected mothers (p <
0.0001). Similarly, in a study of 986 pregnant women
admitted during the rainy season to the obstetric division
of a district hospital in northern Zimbabwe, researchers
found that HIV-infected women were more likely to de-
velop malaria attacks—defined as the presence of asexual
forms of Plasmodium species on a blood smear associated
with fear, headache, chills, and/or joint pain—during their
pregnancies than women who were seronegative (odds
ratio = 3.96, 95% CI: 2.42–6.46) [65]. In a public hospital
in western Kenya, HIV-seropositive women coinfected
with malaria were twice as likely to suffer from anemia as
HIV-seronegative women with or without malaria infec-
tion [66]. These findings are of note because under condi-
tions of climate change and extensions in the ranges of
malaria vectors, the location and frequency of syndemic
interaction of HIV and malaria is likely to increase [67].
Adverse interactions with hepatitis infections, which
share common modes of transmission with HIV, consti-
tute another group of non-opportunistic HIV syndemics
among pregnant women in SSA. Hepatitis C infection
(HCV) is disproportionately common in Africa, which is
reported to have the highest prevalence rate (prevalence =
5.3%) of the world’s regions, while the largest reservoirs
of chronic hepatitis B (HBV) infection are in SSA (preva-
lence = ≥8%) and Asia (prevalence = >8%) [68,69]. HIV is
known to adversely impact the course of both HBV and
HCV infections by accelerating the progression of chronic
liver disease. Among individuals previously exposed to
HBV in which disease development was contained by the
immune system, for example, severe immunosuppression
caused by HIV can lead to HBV reactivation [68]. Both
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among pregnant women, and are believed to be leading
causes of maternal mortality in some SSA nations [70,71].
In a study of HIV/HCV coinfection among 547 pregnant
women attending the antenatal clinic of a medical center
in Ouagadougou, Burkina Faso, Simpore et al. [72] found
that 10.6% were positive for HIV disease and 3.3% for
HCV disease. Seven women in the sample (1.3%) were
dually infected (compared to 76 women with a single
infection), a higher than expected rate “suggesting a cor-
relation between these two infections [72]”. A follow-up
study of 607 women found higher rates of HCV in HIV-
positive women than their HIV-negative counterparts
(2.38% versus 1.75%, respectively), but not at statistically
significant levels (P = 0.81) [73]. Similarly, a study of preg-
nant women in Zambia found somewhat higher levels of
HBV infection among HIV-positive pregnant women [74].
In a study of over 1,000 pregnant women (half HIV-
positive) in Abidjan, Côte d'Ivoire, researchers tested for
HBV and HCV infection [75]. They found that HBV was
more frequent in HIV-positive women (26.7%), com-
pared to HIV-negative women (9.4%). By contrast, there
were no differences in the rates of HCV infection in the
two HIV-status groups. A study in Ibadan, Nigeria also
found greater coinfection with HBV (8.9%) than HCV
(1.9%) in HIV-infected pregnant women [76].
In another study that examined both HBV and HCV
among HIV-positive pregnant women in the region, Okeke
and co-workers [77] implemented a retrospective survey of
approximately 400 HIV-positive pregnant women in
Enugu, Nigeria. The combined prevalence of HIV/HBV
and HIV/HCV coinfection was 6.5%, with HIV/HBV coin-
fection being the more common dual infection pattern. Of
note, a study of six viral infections among pregnant women
(N = 492) and blood donors (N = 191) in rural and urban
(Ouagadougou) Burkina Faso found that 0.6% of partici-
pants were triply infected, with the most common coinfec-
tion array involving HBV, HIV, and human herpesvirus
type 8 (HHV-8) [78]. The same trichotomous syndemic
was examined in a second Burkina Faso study among over
375 women seeking antenatal consultation at Saint Camille
Medical Centre in Ouagadougou [79]. Among HBV-
positive patients, HIV and HHV-8 coinfections were high,
comprising 16.7% and 20%, respectively, of women who
tested positive for hepatitis exposure. Additionally, of the
12.7% of women who were positive for HIV-1, 4.2% also
were coinfected with HIV-2. At the same medical center,
Ouermi and colleagues (2009) [80] investigated coin-
fections of HBV and Toxoplasma gondii—a parasitic pro-
tozoan that causes toxoplasmosis—in HIV-positive and
HIV-negative pregnant women. They found that HIV-
positive status was associated with higher prevalence rates
of both T. gondii (31.9 vs. 22.5%, 95% CI: 24.36–40.43)
and HBV (13.0 vs. 5.8%, 95% CI: 8.12–20.09).As these studies suggest, the extent of the HIV disease/
hepatitis syndemic, along with other coinfections, among
pregnant women in SSA is currently low but higher for
HBV/HIV than HCV/HIV coinfection. Changes in risk
patterns, such as the growing spread of injection drug use
and risky sexual practices among youth and young adults,
however, could alter this profile and produce impactful
syndemics involving HIV and hepatitis [81,82].
HIV interaction with noninfectious diseases and disorders
The third group of diseases and health conditions that
HIV disease interacts with includes various noninfec-
tious diseases and disorders, such as food insufficiency
[83-85]. These terms are defined as persistent lack of ac-
cess to adequate food in needed quantity and quality
(food insecurity), and deficiencies in micronutrients and
macronutrients (undernutrition) [86]. A mother’s nutri-
tional status is a critical determinant of maternal health
[87]. In SSA, HIV disease has spread rapidly among pop-
ulations in which malnutrition is endemic. Syndemic
interaction between these two health threats is centered
in the body’s complex and multilayered host immune
system [88]. In fact, malnutrition and HIV disease are
the two most common causes of acquired immune dys-
function, and the patterning of immune system suppres-
sion caused by malnutrition mirrors, in many ways, the
downgraded immune effects of HIV disease. The path-
ways of interaction are bidirectional. While HIV disease
exacerbates nutrient deficiencies by altering critical
metabolic processes involved in nutrient intake and
utilization, chronic undernutrition weakens the body’s
immune response, leading to reductions in immune cell
populations and immunocompetence. These dynamics
have been identified as a significant threat to pregnant
women in SSA [89-92].
Beyond HIV disease, a range of other infectious syn-
demics impacts the health of pregnant women in SSA.
One of these noteworthy in the region is the interaction
of malaria and helminth infections.
Malaria and helminths
The conditions for a potential syndemic of these two
parasitic infections are created by the overlapping geo-
graphic distributions of mosquito vectors of malaria and
the various species of intestinal helminths. An assess-
ment of over 1,000 febrile patients in southern Ethiopia
found that malaria infection was more common in
patients coinfected with the helminths A. lumbricoides
(21.3%), T. trichiura (23.1%), and S. mansoni (23.1%)
than those patients without a helminth infection (9.3%)
[93]. The prevalence of non-severe malaria was sig-
nificantly higher in individuals infected with specific
helminths (A. lumbricoides-35.9%, T. trichiura-11.7%,
S. mansoni-9.8%, and hookworm-9.8%, respectively) than
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95% CI: 1.13–2.22). Moreover, the odds ratio of having
non-severe malaria increased with the number of intestinal
helminth species infecting a patient (p < 0.001). Coinfected
individuals showed lower mean levels of hemoglobin than
those with malaria infection alone (p = 0.027). The specific
helminth species involved may be critical, as some findings
suggest a protective or counter-syndemic effect with par-
ticular types of intestinal worms and a worsening syndemic
effect with others [94]. Hookworm, for example, falls into
the latter group, which is consequential both because its
prevalence in SSA among pregnant women is high and
because it “may contribute significantly to the degree of
anemia in pregnant women [95]”.
Several hypotheses have been put forward to explain
the nature of the interaction between helminths and
malaria. A review by Mwangi et al. [96] highlights the
possibility that helminth infection creates a cytokine
milieu that is favorable to the production of non-
cytophilic antibodies, making individuals more suscep-
tible to clinical malaria. Alternately, Yazdanbakhsh et al.
[97] suggest that the presence of T-regulatory cells in-
crease during helminth infection, which, if present in suffi-
cient numbers, induce a non-specific immune suppression
that facilitates malaria development upon exposure. As
yet, given the limited availability of studies, the relative
value of these hypotheses remains uncertain [98].
First described over 75 years ago, it is clear that dual
infection of malaria and intestinal helminths presents a
serious threat to the health of pregnant women in SSA
[99]. Varying patterns of coinfection have been described.
A cross-sectional study of women presenting for delivery
at two hospitals in Kumasi, Ghana, found that 19.7% were
positive for the malarial pathogen P. falciparum, 9.1%
were positive for helminth infection without malaria, and
16.6% were coinfected [100]. Several helminths were iden-
tified, including hookworms, A. lumbricoides, T. trichiura,
and S. stercoralis, with the first two being the most com-
mon. Women with intestinal helminths were almost five
times as likely to be infected with malaria as women with-
out a helminth infection. Young age at pregnancy was
found to be strongly associated with dual infection, while
heightened rates of dual infection also were found among
single, low-income, and primagravid women. Hiller et al.
[101] observed “a strong association between asymp-
tomatic infection with P. falciparum and infection with
[the helminth] M. perstans” in a randomized, double-
blind, placebo-controlled treatment study among pregnant
women in Entebbe, Uganda. A weaker association was ob-
served between hookworm and P. falciparum infection.
Egwunyenga et al. [95] randomly selected over 2,000 near-
term pregnant women who delivered at three hospitals in
Nigeria for screening for malaria and helminth parasites.
Their study revealed that over 45% of Plasmodiuminfected women also harbored intestinal helminths.
Women, especially primagravids, with Plasmodium/
intestinal helminth coinfections had lower hemoglobin
levels than those who suffered from malaria infection
alone. This condition was attributed to chronic loss of
blood and iron due to both infections. Anemia was be-
lieved to be further aggravated by the poor nutritional
status of study participants, especially involving limited
access to folate and iron.
Taking the assessment of disease interaction another
step, Crowther et al. [102] examined the interplay of mal-
aria, helminths, and HIV disease among 328 HIV-positive
women attending antenatal centers in Rwanda. They found
that 38% tested positive for helminths, 21% had malaria,
and 10% had dual infection. The most prevalent helminth
was A. lumbricoides (20.7%), followed by T. trichiura
(9.2%). Women with helminth infections were character-
ized by low hemoglobin and CD4 counts (p < 0.05). This
study demonstrates the importance of assessing multi-
disease syndemics among pregnant women. In low-income
settings in particular, pregnant women may be subject to
complex syndemics involving more than two diseases in
adverse interaction.
Mixed infectious/noninfectious syndemics
Syndemics, as indicated, are not limited to pathogen-
pathogen interactions involving infectious diseases, but
also include adverse interplay of infectious and noninfec-
tious diseases. It has been established that some infec-
tions increase the risk of certain noninfectious diseases
and vice versa. Among pregnant women in SSA, this is
seen in the TB/diabetes syndemic. Diabetes considerably
increases risk of early mortality due to TB [103]. This
association may be produced both through the role of
diabetes in impairing immune functions and through its
interference with the effectiveness of pharmaceutical
treatment of TB [104]. Bidirectional impact, involving
TB increasing the risk of diabetes, also has been de-
scribed [15]. Dietary deficiencies, including inadequacies
of vitamins A, C, and D, have been linked to increased risk
for both diabetes and TB [104]. In SSA, diabetes has been
associated with a three-fold incident risk of TB and in-
creased prevalence of diabetes has been identified in pa-
tients with pulmonary TB [105-107]. The precise impact of
the convergence of these two diseases among pregnant
women in SSA, which is expected given the rising preva-
lence of diabetes and the existing prevalence of TB, re-
mains uncertain because as Dooley and Chaisson [108]
found in review of the relevant literature: “Many important
topics have been poorly studied or not studied at all”.
Noninfectious syndemics
Noninfectious syndemics, involving interaction among
chronic diseases and health conditions, are also of
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SSA, this is seen in the interaction of diabetes and un-
dernutrition. Diabetes contributes to anemia during
pregnancy and maternal morbidity [109,110]. Prevalence
rates of gestational Type 2 diabetes are increasing globally
including in SSA [111]. Gestational diabetes (GDM) is as-
sociated with an increased risk for the subsequent devel-
opment of classical diabetes mellitus. While studies of
GDM are limited in African countries [110], one of the
highest rates (3.7%) has been found among rural pregnant
women in northern Ethiopia [112]. In accounting for this
level of prevalence, the authors suggest the importance of
nutritional deficiency: “The only possible reason found to
be a cause for the high prevalence of GDM in this area is
the exposure of these pregnant women to chronic malnu-
trition during their intrauterine life and early child hood
periods. Drought, famine and war have persistently
affected this area where the study was conducted for the
last over 50 years [112]”. In other research, marginal food
security has been found to be significantly associated with
GDM [113].
Conclusion
Pregnant women, particularly in SSA, are an understud-
ied group, but they are more vulnerable to infections be-
cause of suppression of the immune system during
pregnancy and also are at heightened risk for various
noninfectious diseases as well. While amplified vulner-
ability is recognized, epidemiological, biomedical, and
social science of health research about pregnant women
has tended to be characterized by “single disease” ap-
proaches. In this paper, I have reviewed available litera-
ture suggesting the critical importance of adverse
disease interactions of infectious and noninfectious dis-
eases to draw attention to the role of syndemics in ma-
ternal health in the region.
The strength of the findings of this review are limited by
several factors, including the size and significant diversity
of the countries and locales of SSA, the burdens of re-
search common to resource-poor settings, the compara-
tively few studies focused specifically on maternal health
in the region, the dominance of narrowly-focused preva-
lence studies, the small number of ethnographic assess-
ments that present the experience and perspective of
pregnant women on their health, and the restricted atten-
tion paid to comorbidity, let alone to the nature, pathways
and consequences, of disease interaction. Nonetheless, the
available literature is adequate to suggest the salience
of the syndemics of pregnancy in the countries under
examination. Capacity-strengthening efforts designed to
improve the number and quality of syndemic “burden-of-
disease” studies could provide critical knowledge for the
implementation of programs capable of improving the
quality of care and maternal health in SSA. Such studieswould explore the constellation of diseases of pregnant pa-
tients; would investigate locally-identified syndemics and
their health effects during pregnancy including the pat-
terns of presentation of specific interacting diseases, the
social conditions that foster disease clustering and inter-
action among pregnant women; and involve trials of inte-
grated treatment regimens designed to treat multiple
co-occurring diseases in this population.
Ray and co-authors [114] argue that “failure to reduce
preventable maternal deaths represents a violation of
women’s right to life, health, non-discrimination and
equality.” They advocate an activist approach, involving
collaboration of health professionals and non-government
civil organizations for improving material health in the
African context. As a model for such an initiative, they
point to grassroots HIV activism and its successful rights-
based challenge. Thus, they note: “With regard to mater-
nal mortality, where the majority of deaths are preventable
and in many countries occur in health institutions, there
are opportunities to learn from the successes of HIV cam-
paigns in making health services more responsible to
women’s needs [114]”. As an example of this kind of activ-
ism in women’s health, they point to the Treatment Action
Campaign in South Africa, which used a right to health
approach, community empowerment, popular mobili-
zation, and legal action. The syndemics model, which em-
phasizes the social origins of disease and the need for
health care response to the entwined biosocial complex-
ities of living conditions, gender discrimination, pregnancy
under conditions of poverty, and the role of a constellation
of interacting diseases can inform activist efforts to im-
prove maternal health in SSA.
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